These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10087003)

  • 1. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts.
    Neumann J; Maas R; Bokník P; Jones LR; Zimmermann N; Scholz H
    J Pharmacol Exp Ther; 1999 Apr; 289(1):188-93. PubMed ID: 10087003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cantharidin effects on protein phosphatases and the phosphorylation state of phosphoproteins in mice.
    Eldridge R; Casida JE
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):95-100. PubMed ID: 7839375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.
    Münch G; Bölck B; Karczewski P; Schwinger RH
    J Mol Cell Cardiol; 2002 Mar; 34(3):321-34. PubMed ID: 11945024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of endogenous cardiac phosphatase activity and measurement of sarcoplasmic reticulum calcium uptake: a possible role of phospholamban phosphorylation in the hypertrophied myocardium.
    Boateng S; Seymour AM; Dunn M; Yacoub M; Boheler K
    Biochem Biophys Res Commun; 1997 Oct; 239(3):701-5. PubMed ID: 9367832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum.
    Kranias EG; Di Salvo J
    J Biol Chem; 1986 Aug; 261(22):10029-32. PubMed ID: 3015916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of the in vivo phosphorylation status of phospholamban in the heart: evidence for a site-specific difference in the dephosphorylation of phospholamban.
    Calaghan S; White E; Colyer J
    Biochem Biophys Res Commun; 1998 Jul; 248(3):701-5. PubMed ID: 9703990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability.
    Knapp J; Bokník P; Lüss I; Huke S; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Noll T; Piper HM; Schmitz W; Vahlensieck U; Neumann J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1480-6. PubMed ID: 10336542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of cantharidin in smooth muscle.
    Knapp J; Bokník P; Huke S; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
    Br J Pharmacol; 1998 Mar; 123(5):911-9. PubMed ID: 9535020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.
    Bartel S; Vetter D; Schlegel WP; Wallukat G; Krause EG; Karczewski P
    J Mol Cell Cardiol; 2000 Dec; 32(12):2173-85. PubMed ID: 11112993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme.
    Steenaart NA; Ganim JR; Di Salvo J; Kranias EG
    Arch Biochem Biophys; 1992 Feb; 293(1):17-24. PubMed ID: 1309982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alteration of phospholamban phosphatase activity associated with cardiac sarcoplasmic reticulum during sepsis in rats].
    Yang Q; Wu LL; Tang X; Tang CS
    Sheng Li Xue Bao; 1995 Aug; 47(4):357-65. PubMed ID: 7481877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and regulation of serine/threonine phosphatases in the healthy and diseased heart.
    Heijman J; Dewenter M; El-Armouche A; Dobrev D
    J Mol Cell Cardiol; 2013 Nov; 64():90-8. PubMed ID: 24051368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein phosphorylation in rat cardiac microsomes: effects of inhibitors of protein kinase A and of phosphatases.
    Sulakhe PV; Vo XT; Morris TE; Pato MD; Khandelwal RL
    Mol Cell Biochem; 1997 Oct; 175(1-2):109-15. PubMed ID: 9350040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure.
    DiPaola NR; Sweet WE; Stull LB; Francis GS; Schomisch Moravec C
    J Mol Cell Cardiol; 2001 Jun; 33(6):1283-95. PubMed ID: 11444930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical unloading of the rat heart involves marked changes in the protein kinase-phosphatase balance.
    Schwoerer AP; Neuber C; Schmechel A; Melnychenko I; Mearini G; Boknik P; Kirchhefer U; Schmitz W; Ehmke H; Eschenhagen T; El-Armouche A
    J Mol Cell Cardiol; 2008 Dec; 45(6):846-52. PubMed ID: 18848565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of protein phosphatases 1 and 2A in collagen-platelet interaction.
    Chiang TM
    Arch Biochem Biophys; 1993 Apr; 302(1):56-63. PubMed ID: 8385905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast protein phosphatase active with acidic ribosomal proteins.
    Pilecki M; Grzyb A; Zień P; Sekuła O; Szyszka R
    J Basic Microbiol; 2000; 40(4):251-60. PubMed ID: 10986671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
    Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
    J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
    El-Armouche A; Boknik P; Eschenhagen T; Carrier L; Knaut M; Ravens U; Dobrev D
    Circulation; 2006 Aug; 114(7):670-80. PubMed ID: 16894034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.